Targeted Medical Pharma(OTC) TRGM

Targeted Medical Pharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing amino acid-based medications. The company operates under the name Physician Therapeutics, providing innovative medical food products and dietary supplements to address various health conditions.

Products and Services

• Patented amino acid-based medical food products
• Dietary supplements for metabolic syndrome and sleep disorders
• Proprietary billing process and software for physician dispensing

Growth Outlook

• Expanding product line to meet increasing demand in healthcare
• Strong focus on addressing metabolic syndrome and obesity
• Potential for growth through partnerships with healthcare providers

Financial Highlights

• Recent quarterly revenue of 1,288,658, showing a steady demand
• Gross profit margin of 60.2% indicates strong product profitability
• Operating cash flow of 76,543 reflects operational efficiency

Targeted Medical Pharma, Inc. is positioned in the healthcare sector, specifically within the pharmaceuticals industry. The company has developed a range of products aimed at treating various conditions, including metabolic syndrome, sleep disorders, and pain management. The proprietary billing process and software enhance the efficiency of physician dispensing, which is a significant value-add for healthcare providers. The growth outlook for Targeted Medical Pharma appears promising, with an expanding product line that aligns with the increasing demand for effective healthcare solutions. The focus on metabolic syndrome and obesity is particularly relevant given the rising prevalence of these conditions in the population. Additionally, potential partnerships with healthcare providers could further enhance market reach and product adoption. Financially, the company has demonstrated a solid revenue stream, with recent quarterly figures indicating a revenue of 1,288,658. The gross profit margin of 60.2% suggests that the products are not only in demand but also profitable. Furthermore, the positive operating cash flow of 76,543 indicates that the company is managing its operations effectively, which is crucial for sustaining growth and funding future initiatives. Overall, Targeted Medical Pharma, Inc. presents an intriguing opportunity for investors interested in the healthcare and pharmaceutical sectors, particularly those focused on innovative solutions for prevalent health issues.